Maurice Slevin

Slevin graduated from the University of Cape Town and completed his postgraduate training at Groote Schuur Hospital in Cape Town and St Bartholomew's Hospital in London, where he worked as head of chemotherapy for solid cancers.{{cite web |title=Reunions held in 2013: Class of 1973 reunion |url=https://health.uct.ac.za/alumni-reunions-reunion-roundup-reunions-held-2013/class-1973 |website=UCT Faculty of Health Sciences |access-date=2024-09-09}}{{cite web |title=Team |website=Fcancer |url=https://fcancer.org/about/team |access-date=2024-09-09}}{{cite web |title=St. Bartholomew's and Royal London Hospitals (Hansard, 6 July 1993) |website=api.parliament.uk |date=1993-07-06 |url=https://api.parliament.uk/historic-hansard/commons/1993/jul/06/st-bartholomews-and-royal-london |access-date=2024-09-09}} He is a Fellow of the Royal College of Physicians.

His research primarily focused on clinical pharmacology, with particular emphasis on etoposide and cytosine arabinoside, as well as psychosocial oncology.{{cite web |title=How doctors care for their own families' futures |website=The Telegraph |date=2016-02-23 |url=https://www.telegraph.co.uk/sponsored/property/london-property-investments/12168812/doctors-invest-in-london-property-funds.html |access-date=2024-09-09}}{{cite journal |vauthors=Slevin ML, Clark PI, Joel SP, Malik S, Osborne RJ, Gregory WM, Lowe DG, Reznek RH, Wrigley PF |title=A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer |journal=Journal of Clinical Oncology |volume=7 |issue=9 |pages=1333–40 |date=September 1989 |pmid=2549204 |doi=10.1200/JCO.1989.7.9.1333 |url=}}{{cite journal |vauthors=Slevin ML, Piall EM, Aherne GW, Harvey VJ, Johnston A, Lister TA |title=Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid |journal=Journal of Clinical Oncology |volume=1 |issue=9 |pages=546–51 |date=September 1983 |pmid=6583325 |doi=10.1200/JCO.1983.1.9.546 |url=}}{{cite journal |vauthors=Slevin ML, Stubbs L, Plant HJ, Wilson P, Gregory WM, Armes PJ, Downer SM |title=Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public |journal=BMJ (Clinical Research Ed.) |volume=300 |issue=6737 |pages=1458–60 |date=June 1990 |pmid=2379006 |pmc=1663147 |doi=10.1136/bmj.300.6737.1458 |url=}} He has published over 150 peer-reviewed papers in academic journals and has an h-index of 58.{{cite web |title=Massachusetts General Hospital and other places |website=ResearchGate |date=2008-04-01 |url=https://www.researchgate.net/scientific-contributions/M-L-Slevin-39982565 |access-date=2024-09-09}}

He helped establish the cancer support charity Cancerbackup, which he chaired from 1985 to 2008, when it merged with Macmillan.{{cite journal |vauthors=Slevin ML, Terry Y, Hallett N, Jefferies S, Launder S, Plant R, Wax H, McElwain T |title=BACUP--the first two years: evaluation of a national cancer information service |journal=BMJ (Clinical Research Ed.) |volume=297 |issue=6649 |pages=669–72 |date=September 1988 |pmid=3140928 |pmc=1834344 |doi=10.1136/bmj.297.6649.669 |url=}}{{cite web |title=The history of Macmillan |website=Macmillan Cancer Support |url=https://www.macmillan.org.uk/about-us/organisation/history |access-date=2024-09-09}}{{cite web |last=Lake |first=Howard |title=Macmillan Cancer Support and Cancerbackup to merge |website=UK Fundraising |date=2008-01-12 |url=https://fundraising.co.uk/2008/01/12/macmillan-cancer-support-and-cancerbackup-merge/ |access-date=2024-09-09}}{{cite web |last=Cornish |first=Jenny |title=Mergers: Who's the leader of the brand? |website=Third Sector |date=2010-07-16 |url=https://www.thirdsector.co.uk/mergers-whos-leader-brand/communications/article/1016646 |access-date=2024-09-09}}

Slevin and his colleagues carried out a study, funded by the Imperial Cancer Research Fund, which showed that cancer patients were more likely to opt for radical and intensive treatment with minimal chance of benefit than were their doctors.{{cite web |last=Read |first=Cathy |title=Health: When is it time to give in to cancer?: Some doctors believe |website=The Independent |date=1994-02-15 |url=https://www.independent.co.uk/life-style/health-and-families/health-news/health-when-is-it-time-to-give-in-to-cancer-some-doctors-believe-that-we-overtreat-patients-who-would-need-a-miracle-to-survive-their-disease-cathy-read-reports-1394275.html |access-date=2024-09-09}}

Slevin gained attention for his controversial papers on the National Health Service (NHS), where he argued that reform was more crucial than increased funding.{{cite web |last=Carvel |first=John |title=NHS on brink of implosion, claims leading specialist |website=The Guardian |date=2003-02-04 |url=https://www.theguardian.com/society/2003/feb/04/NHS.politics |access-date=2024-09-09}}{{cite web |title=NHS is crushed by red tape, say consultants |website=The Telegraph |date=2003-02-04 |url=https://www.telegraph.co.uk/education/3307639/NHS-is-crushed-by-red-tape-say-consultants.html |access-date=2024-09-09}} He suggested that the NHS had almost as many managers as nurses, a claim that was slammed by the NHS federation.{{cite web |title=Managers fight back over consultants claims |website=Public Finance |date=2003-02-06 |url=https://www.publicfinance.co.uk/news/2003/02/managers-fight-back-over-consultants-claims |access-date=2024-09-09}} He led a movement in 2000 demanding a wholesale overhaul of NHS treatment of the disease, along with Karol Sikora, in which they argued for faster cancer treatment timelines.{{cite web |last=Templeton |first=Sarah-Kate |title=Experts push NHS to use US style cancer care |website=The Times & The Sunday Times |date=2007-08-26 |url=https://www.thetimes.com/article/experts-push-nhs-to-use-us-style-cancer-care-s7r3m09trhk |access-date=2024-09-09}}

Slevin was a founder member of Doctors for Reform, a group of 1000 consultants who advocated a social insurance model of funding the NHS.{{cite web |title=Calls for 'NHS tax' to finance health care |website=The Telegraph |date=2007-06-02 |url=https://www.telegraph.co.uk/news/uknews/1553362/Calls-for-NHS-tax-to-finance-health-care.html |access-date=2024-09-09}}

Slevin has over 150 published peer-reviewed papers in academic journals, including:{{cite web |title=Maurice Slevin |website=PubMed |url=https://pubmed.ncbi.nlm.nih.gov/?term=maurice+slevin |access-date=2024-09-09}}{{cite web |title=Maurice Slevin |website=Google Scholar |url=https://scholar.google.com/citations?user=jf_0bHgAAAAJ |access-date=2024-09-09}}

• {{cite journal |last1=Slevin |first1=M L |last2=Clark |first2=P I |last3=Joel |first3=S P |last4=Malik |first4=S |last5=Osborne |first5=R J |last6=Gregory |first6=W M |last7=Lowe |first7=D G |last8=Reznek |first8=R H |last9=Wrigley |first9=P F |title=A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer. |journal=Journal of Clinical Oncology |volume=7 |issue=9 |date=1989 |issn=0732-183X |doi=10.1200/JCO.1989.7.9.1333 |pages=1333–1340|pmid=2549204 }}
• {{cite journal |last1=Clark |first1=P I |last2=Slevin |first2=M L |last3=Joel |first3=S P |last4=Osborne |first4=R J |last5=Talbot |first5=D I |last6=Johnson |first6=P W |last7=Reznek |first7=R |last8=Masud |first8=T |last9=Gregory |first9=W |last10=Wrigley |first10=P F |title=A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicity. |journal=Journal of Clinical Oncology |volume=12 |issue=7 |date=1994 |issn=0732-183X |doi=10.1200/JCO.1994.12.7.1427 |pages=1427–1435|pmid=8021734 }}
• {{cite journal |last=Slevin |first=M L |title=Low-dose oral etoposide: a new role for an old drug? |journal=Journal of Clinical Oncology |volume=8 |issue=10 |date=1990 |issn=0732-183X |doi=10.1200/JCO.1990.8.10.1607 |pages=1607–1609|pmid=2170588 }}
• {{cite journal |last1=Slevin |first1=M L |last2=Piall |first2=E M |last3=Aherne |first3=G W |last4=Harvey |first4=V J |last5=Johnston |first5=A |last6=Lister |first6=T A |title=Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid. |journal=Journal of Clinical Oncology |volume=1 |issue=9 |date=1983 |issn=0732-183X |doi=10.1200/JCO.1983.1.9.546 |pages=546–551|pmid=6583325 }}
• {{cite journal |vauthors=Slevin ML, Piall EM, Aherne GW, Johnston A, Sweatman MC, Lister TA |title=The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia |journal=British Journal of Clinical Pharmacology |volume=12 |issue=4 |pages=507–10 |date=October 1981 |pmid=6945865 |pmc=1401912 |doi=10.1111/j.1365-2125.1981.tb01258.x}}
• {{cite journal |vauthors=Slevin ML, Stubbs L, Plant HJ, Wilson P, Gregory WM, Armes PJ, Downer SM |title=Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public |journal=BMJ (Clinical Research Ed.) |volume=300 |issue=6737 |pages=1458–60 |date=June 1990 |pmid=2379006 |pmc=1663147 |doi=10.1136/bmj.300.6737.1458}}
• {{cite journal |vauthors=Slevin M, Mossman J, Bowling A, Leonard R, Steward W, Harper P, McIllmurray M, Thatcher N |title=Volunteers or victims: patients' views of randomised cancer clinical trials |journal=British Journal of Cancer |volume=71 |issue=6 |pages=1270–4 |date=June 1995 |pmid=7779722 |pmc=2033847 |doi=10.1038/bjc.1995.245}}
• {{cite journal |vauthors=Slevin ML, Terry Y, Hallett N, Jefferies S, Launder S, Plant R, Wax H, McElwain T |title=BACUP--the first two years: evaluation of a national cancer information service |journal=BMJ (Clinical Research Ed.) |volume=297 |issue=6649 |pages=669–72 |date=September 1988 |pmid=3140928 |pmc=1834344 |doi=10.1136/bmj.297.6649.669}}

{{reflist}}

{{Authority control}}

{{DEFAULTSORT:Slevin, Maurice}}

Category:Living people

Category:University of Cape Town alumni

Category:British oncologists

Category:21st-century British medical doctors

Category:Fellows of the Royal College of Physicians

Category:Year of birth missing (living people)